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Background: Fatigue is described as a persisting sensation of tiredness and exhaustion that 
potentially interferes with daily life functioning. Since the first descriptions of AIDS, fatigue 
has been the most noted symptom, but to our knowledge, fatigue has never been investigated 
among people living with HIV (PLWH) in Norway. 
 
Objectives: The aim is to investigate the prevalence and the predictors of fatigue among PLWH 
in Northern and Southern Norway. 
 
Material and methods: A cross-sectional survey was conducted between December 2014 and 
September 2015 at two hospitals. The survey consisted of hospital records and a structured 
interview containing eight instruments. Fatigue was defined as a score of four points or more 
on the Chalder Fatigue Scale, and factors associated with fatigue were assessed with logistic 
regression analyses. 
 
Results: 244 patients; 94 fatigued (38.5%) and 150 non-fatigued; were included in the analysis. The 
final regression model consisted of ten covariates; age, gender, men who have sex with men, 
CD4+ count, living alone, high education, multimorbidity, mental distress, bodily pain and 
trouble sleeping. The strongest predictors of fatigue were symptoms of anxiety and depression 
measured as presence of mental distress (aOR 8.98, 95% CI 3.81-21.15) and increased bodily 
pain on a scale from 0-10 (aOR 1.44, 95% CI 1.25-1.67). Other significant predictors were 
living alone (aOR 2.99, 95% CI 1.36-6.56), trouble sleeping (aOR 2.67, 95% CI 1.06-6.71) and 





Conclusion: The prevalence of fatigue among people living with HIV in Southern and Northern 
Norway is 38%, almost two times higher than the estimated prevalence in the Norwegian 
general population (22%). We identified mental distress, bodily pain, trouble sleeping, living 
alone and multimorbidity as predictors of fatigue. PLWH live longer due to highly effective 
antiretroviral therapy and improving their quality of life is important. If fatigue and its 
predictors, like mental distress and bodily pain, are identified and addressed, it may improve 
the quality of life for many. More research on prevention and treatment strategies for fatigued 
PLWH is needed, and should be implemented in the daily clinical routines.  
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1 Introduction 
The human immunodeficiency virus (HIV) was first described in 1984 as the cause of acquired 
immune deficiency syndrome (AIDS), and HIV/AIDS soon became a worldwide epidemic 
(Sepkowitz, 2001). Major improvements for people living with HIV (PLWH) came with access 
to antiretroviral therapy (ART), especially in the industrialized part of the world. Potent ART 
has transformed HIV from a death sentence to a chronic illness, and the goal of HIV-care has 
shifted from delaying death to achieving optimal health. Since the first descriptions of AIDS, 
fatigue has been the most noted symptom. Fatigue affects mental and physical functioning 
which in turn interfere with family, work and social life (Barroso et al., 2014). Understanding 
HIV-related fatigue in order to prevent or treat, can improve the quality of life for many. A 
review from 2010 identified mental health as the strongest predictor of fatigue along with 
comorbidity, sleeping difficulties, use of ART, unemployment and inadequate income (Jong et 
al., 2010).  This study aims to find the prevalence and investigate the predictors of fatigue in 
PLWH in Northern and Southern Norway1.  
1.1 Objectives 
Objectives: 
1) Investigate the prevalence of fatigue among PLWH in Northern and Southern Norway. 
2) Investigate the predictors of fatigue among mental health, socio-demographic, HIV- and 
other health related factors. 
Hypotheses: 
1) There is a high prevalence of fatigue among people living with HIV in Norway.  
2) Depression is positively associated with fatigue and is the strongest predictor of fatigue. 
                                                     
1 Norther Norway is here the counties Troms with Svaldbard, Finnmark and parts of Nordland. And Southern 
Norway is the two Agder counties (and must not be confused with South Norway).  
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2 Background 
2.1 HIV epidemiology 
UNAIDS estimated approximately 36.7 million people living with HIV in 2016. In a global 
perspective, the number of new HIV cases peaked in 1997, and AIDS related deaths have 
steadily decreased since 2006 due to better antiretroviral treatment (Trickey et al., 2017). In 
Norway 213 new cases of HIV were registered in 2017 through The Norwegian Surveillance 
System of Communicable Diseases (MSIS), and by the end of 2017 a total of 6277 people have 
tested positive for HIV since the registration started in 1984 (NIPH., 2018). Twice as many 
men (4260) than women (2017) have been registered. The MSIS registrations do not give a 
total number of people living with HIV in Norway today, since some are deceased or have 
moved abroad. The planned Norwegian quality register for HIV (NORHIV) estimates that 3425 
people lived with HIV in 2015 (NORHIV, Bergersen, B.M., 2016) whereas 5843 were 
registered in MSIS the same year. The NORHIV number was based on National Patients 
Registry-codes (NPR-codes), a disease specific code sent electronically from the hospitals after 
all consultations. Norway has universal health care coverage, and PLWH receive consultations, 
medications and other HIV-related services without any personal cost at the public hospitals. 
The NPR codes, though probably slightly underestimated, offer a good estimate of the number 
of people living with HIV in Norway. The Norwegian population consisted in 2015 of 5.16 
million inhabitants (SSB, 2015), and the estimated prevalence of HIV in Norway is then 
66/100.000.  
Most of the PLWH in Norway live in the capital; more than 46% are registered as patients at 
Oslo University Hospital (OUS). Of the remaining 18 hospitals, 9 follow up 100-300 patients 
each, and 9 follow up less than 90 patients each (NORHIV, Bergersen, B.M., 2016). Men 
infected with HIV through homosexual transmission are referred to as men who have sex with 
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men (MSM). MSM has a high prevalence of HIV on all continents (Beyrer et al., 2012), and 
there is an increased trend of HIV transmission among MSM in Norway (Jakopanec et al., 
2013). In Norway 33% of all cases of HIV in MSIS were registered with homosexual 
transmission and the number for OUS is 47%. Many PLWH are not native Norwegians, but 
have migrated from high endemic countries. Africa is the dominating continent; 77% of those 
who got HIV from heterosexual transmission before arrival to Norway were born in Africa 
(NIPH., 2018). The Norwegian Institute of Public Health (NIPH) estimates that 1600-1800 
immigrants with HIV lived in Norway in 2017.  
2.2 HIV-related fatigue 
Fatigue is one of the most prevalent and bothersome symptoms of HIV, and has a strong impact 
on people’s quality of life as it affects mental and physical functioning, which in turn interfere 
with family, work and social life (Barroso et al., 2014; Wilson et al., 2016). In international 
studies the reported prevalence of fatigue varies from 33-88% in PLWH (Henderson et al., 
2005; Jong et al., 2010), and from 7-42% in the general population (Finsterer and Mahjoub, 
2014; Lewis and Wessely, 1992). The prevalence of fatigue in the general Norwegian 
population is estimated to be 22% (Loge et al., 1998). In healthy individuals fatigue after 
physical activity is expected, but in people suffering from various diseases, fatigue may endure 
after rest and is described as an overwhelming sense of tiredness, lack of energy, inertia or 
fragility that increase with activity and reduce the person’s normal capacities (Barroso and 
Voss, 2013; Davis and Walsh, 2010) 
In general, long time stress or disease are related to fatigue, and fatigue is furthermore 
influenced by age, gender, personality type, life experience, physical activity and nutrition 
(Finsterer and Mahjoub, 2014). In healthy working individuals disturbed sleep is found to be 
the strongest predictor of fatigue along with high work demands, low social support, being 
female and having high age (Akerstedt et al., 2004). Fatigue is a known symptom in chronic 
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diseases such as cardiopulmonary, endocrine, metabolic, hematologic, neoplastic, infectious, 
rheumatologic, psychological and neurological conditions (UpToDate, Chirelli, C., 2018), and 
HIV-related fatigue intensity increases with the number of comorbidities (Corless et al., 2008). 
Explanatory factors are high stress level from loss of social position and social support, disease 
labeling, coping patterns, reduced physical activity and chronic inflammation (Kurien et al., 
2013, Jong et al., 2010). In addition, misuse of alcohol and drugs is associated with fatigue 
(UpToDate, Fosnocht, K.F., 2018). The causal patterns of fatigue are complex and involve 
mechanisms within muscle fibers, metabolic accumulation, proinflammatory cytokines and 
inadequate function in the motor cortex (Dantzer et al., 2008; Abd-Elfattah et al., 2015; 
Finsterer and Mahjoub, 2014). The mechanisms of fatigue will not be discussed further in this 
study. 
A 2010 review of 42 studies found that the strongest predictors of HIV-related fatigue were 
psychological factors like depression and anxiety. Significant associations were also 
established for the socio-demographic variables unemployment and inadequate income, and the 
physiological factors sleep disturbance, comorbidity and ART-use (Jong et al., 2010). 
Conflicting results exist with regard to the association of fatigue with variables such as gender, 
age, ethnicity, having children or partner, education level, sexual orientation, time since 
diagnose, CD4+ count and virus load has been observed in some studies, but not found 
significant in other (Barroso et al., 2010; Henderson et al., 2005; Millikin et al., 2003; Jong et 
al., 2010). 
An overview of fatigue symptom management from 2017 divided associations of HIV-related 
fatigue into three dimensions; physiological, psychological and behavioral (Perazzo et al., 
2017). The main psychological factors in this overview are depression, anxiety, traumatic 
events and social isolation. Psychological factors are anemia, chronic inflammation, endocrine 
dysfunction and side effects of ART, while behavioral factors are physical inactivity and poor 
 
Page 5 of 40 
sleep hygiene. The association of ART and fatigue is often related to disturbance in sleep 
(Gakhar et al., 2013), and sound sleeping habits are important for optimal functioning since 
sleep and fatigue correlate to cognitive impairment (Byun et al., 2016). 
The strong correlation of fatigue with psychological factors like depression, is acknowledged 
(Millikin et al., 2003; Slot et al., 2015; Perazzo et al., 2017; Voss et al., 2007; Jong et al., 2010). 
Depression is the most common mental disorder among PLWH, affecting twice as many as in 
the general population, but is often under-diagnosed and poorly met by the health care services 
(Whetten et al., 2008; Noh et al., 2012; Rodkjaer et al., 2010). There is an association between 
depression and poor ART-adherence (Huynh et al., 2013; Ingersoll and Cohen, 2008; Corless 
et al., 2013), and there are indications that fatigue is negatively related to ART-adherence (Gay 
et al., 2011; Al-Dakkak et al., 2013). The high depression rate is explained by stigma 
experience, emotional reactions after HIV diagnosis, effects of HIV on the brain, side effects 
of ART and of opportunistic infection treatments (Chandra et al., 2005) and is associated with 
reduced quality of life (Whetten et al., 2008; Corless et al., 2013). There is also a direct 
association between fatigue and reduced quality of life (Voss et al. 2006) and overall, PLWH 
report lower quality of life than the general public despite good adherence, viral suppression 
and a stable immune system (Miners et al., 2014).  
As PLWH life expectancy rises with improved treatment, new questions arise about their 
quality of life and how it may be improved. Therefore, data on fatigue is requested for the well 
treated Norwegian PLWH. A 2008 study on fatigue and comorbidity used data from five 
countries including Norway, but the results were not presented by country (Corless et al., 2008). 
Thus, to our knowledge, this will be the first study on prevalence and predictors of fatigue 
among PLWH in Norway.  
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3 Materials and Methods 
3.1 Material 
The data collection was performed between 2014 and 2015 as part of the Mental health and 
quality of life among PLWH in Northern and Southern Norway Survey. The study has a cross-
sectional design. In Norway, the care for PLWH is organized by the secondary health care 
service, and all medication must be prescribed by a specialist in infectious diseases. This study 
is a collaboration between two hospitals, the Southern Hospital of Norway (SSHF) and the 
University hospital of North Norway (UNN). The two hospitals follow up patients in the 
northern and southern counties in Norway, and the counties include both rural and urban areas. 
Together they follow up 8% of all PLWH in Norway (NORHIV., 2016). 
3.1.1 Pilot-study 
A pilot-study was performed in 2012, to test the feasibility of the study and to estimate the time 
required to conduct the survey. The pilot-study identified a high prevalence of depression and 
anxiety among PLWH. The study, which was completed with the help of a medical student, 
took two hours, and some instruments were replaced in order to reduce the time spent. In 
addition, variables about comorbidity and socio-demographics were added.  
3.1.2 Ethical considerations 
The study is approved by REK NORD, Regional ethics committee in Northern Norway, (ref 
2011/1925). Participating in the study was voluntary, and all patients were informed about the 
study orally and in writing, and had to sign a written consent form before inclusion. All 
information from the survey is kept confidential. Patients were offered extra consultations at 
the outpatient clinics after the interview if anything came up that had to be addressed concerning 
their mental health. 
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3.1.3 Organizing and funding 
The Project group consisted of Vegard Skogen, M.D., Ph.D., specialist in clinical microbiology 
and infectious diseases, UNN and University of Tromsø, The Arctic University (UiT), Tore 
Sørlie, M.D., Ph.D., specialist in psychiatry, UNN and UiT, Ole Rysstad, M.D., specialist in 
pulmonary diseases, SSHF, and Birgit Lie, M.D., Ph.D., specialist in community medicine and 
General Practitioner, SSHF. 
All data was collected at the outpatient clinics at the hospitals. The study was mostly funded 
through the regular budget, and external funding was obtained from the Norwegian Directorate 
of Health and was used as salary for a research nurse at UNN. 
3.1.4 Study Population 
All HIV-positive patients above 18 years, registered at the HIV outpatient clinics at SSHF and 
UNN were eligible to participate in the study. The patients were asked to participate regardless 
of language and literacy. Patients with a severe mental disorder or cognitive impairment that 
would make them incapable of answering the questions, were excluded.  
3.1.5 Inclusion period 
The HIV-positive patients have regular visits at least one to four times a year at the outpatient 
clinics. The survey was conducted as a formalized interview following the regular consultation. 
The interview consisted of eight instruments with a total of 147 questions. A nurse performed 
the interviews in Norwegian, English or French, and professional pre-informed interpreters 
were used when needed (n=13). The interview lasted from 30 to 60 minutes, and all interviews 
were conducted between December 2014 and September 2015. Data on medications, 
comorbidities and blood test results were extracted from the medical records. 
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3.1.6 Data management 
Paper schemes were used during the structured interview at UNN. At SSHF, the answers were 
typed directly into the journal system, DiaGraphIT GoTreatIT® Infection, and only a few paper 
schemes were used. All the paper schemes were punched into the journal system and later 
double checked by two nurses. The data were extracted from GoTreatIT® through Windows 
Excel to IBM Statistical Package for Social Science version 24 (SPSS). The study data are 
saved according to local procedures in a secured research database at UNN. 
3.2 Methods 
3.2.1 Dependent variable 
Fatigue was measured with the Chalder Fatigue Scale, also known as the Fatigue Questionnaire 
(FQ), a validated scale of mental and physical fatigue (Jackson, 2015; Chalder et al., 1993). 
The 11 questions in FQ were answered “less than usually”, “as usually”, “more than usually” 
or “much more than usually”. A bimodal score grades the answers 0-0-1-1, with total score 
between 0 and 11, where fatigue is defined as a score of four points or more. This definition of 
fatigue was used as the dependent variable in the analysis. Non-fatigued and fatigued 
participants are presented as fatigued 0=no, 1=yes. The FQ also contains two extra questions 
about duration of fatigue,  this information was used to identify the chronically fatigued. In 
chronic fatigue, symptoms of fatigue must have persisted for more than 6 months.  
3.2.2 Independent variables 
The independent variables were selected based on results from Jong’s systematic review (Jong 
et al., 2010), Barroso’s articles (Barroso et al., 2010; Barroso et al., 2016; Barroso et al., 2014), 
a literature search from 2017 (Loades and Kagee, 2017), and information on chronic diseases 
and substance abuse related to fatigue (Perazzo et al., 2017; UpToDate, Fosnocht, K.F., 2018, 
Guaraldi et al., 2014). Jong and colleagues (2010) identified the strongest predictors of fatigue 
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to be unemployment, inadequate income, use of ART, comorbidity, sleeping difficulty, 
depression and anxiety; Barraso and colleagues (2010, 2014, 2016) list unemployment, ART, 
time since diagnosis, stressful life events, and psychological distress as important variables; 
and Loades and Kagee (2017) identified functional sleep, viral load, CD4+ count, age, gender, 
transmission route, adherence to ART, pain and social-, educational- and occupational 
functioning as factors to be assessed in future research.. This survey did not contain information 
on income, but other socio-demographic variables (education, native country and cohabitation) 
were added.  
3.2.2.1 Socio-demographic variables 
Socio-demographic variables are age, gender, hospital, education, cohabitation, employment 
and native country.  
• Age was measured in years and used as a continuous variable. 
• Gender was coded female=0, male=1. 
• The variable hospital represents the hospital where the participants performed the 
survey, University Hospital of North Norway or Hospital of Southern Norway.  
• Education was registered in number of years in school and presented as 0=low 
education (≤12 years) and 1=high education (>12 years).    
• Work status was answered with 13 different alternatives, the four largest groups (full-
time job, unemployed, disabled pensioner and student) were kept unaltered, and the 
remaining groups were collapsed into “other”. The group “student” includes settled 
immigrants participating in the Norwegian introductory course. The original grouping 
is displayed in appendix Table 6.  
• Cohabitation was calculated based on marital status and whether the participants lived 
with a partner or not. The variable is presented as living together=0 and living alone=1. 
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• Native country is the country where the participant was born. The 50 different countries 
listed, except for Norway, were merged into four continents; Europe, Asia, South-
America and Africa. Native Norwegians were kept as reference group.   
3.2.2.2 HIV and health related variables 
The HIV-related variables are time since diagnosis, transmission route, virus suppression, 
CD4+ count, ART, and treatment failure. The other health related variables are hepatitis C, 
bodily pain, anaemia, comorbidity/multimorbidity and trouble sleeping.  
• The continuous variable time since diagnosis was computed in years from the date of 
study inclusion minus the date of first consultation or positive HIV-test.  
• Transmission route was coded into four categories: 1=heterosexual, 2=MSM 
(homosexual), 3=other (blood transfusion, mother to child or infected syringes) and 
4=unknown. In addition, transmission was dichotomized as MSM, coded 0=no, 1=yes,  
• CD4+ count was measured as absolute count of CD4+ T Lymphocyte cells (x109/L) in 
the blood (CD4+ (x109/L)), and was kept without alterations as a continuous variable. 
• Virus suppression was defined as less than 50 ribonucleic acid copies (RNA) per ml 
blood, and presented as virus suppressed 0=no, 1=yes. 
• Antiretroviral therapy (ART) are participants who used HIV-medication, presented as 
ART 0=no and 1=yes. Participants who started medication on the same day as they 
were included in the study were set as 0.  
• Treatment failure was defined as not virus suppressed after 6 months of treatment, 
(>50 HIV RNA/ART >6 months) and presented as treatment failure 0=no, 1=yes.  
Participants who started ART less than 6 months before the inclusion date were kept 
out of the equation.  
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• Hepatitis C antibody was extracted from the blood samples and presented as positive 
hepatitis C antibody test 0=no, 1=yes. 
• Anaemia was calculated from haemoglobin blood levels. The reference values from the 
UNN laboratory were used as cut off points for anaemia; <11.5 (g/dl) for women and 
<13.0 (g/dl) for men (0=no, 1=yes). 
• Comorbidity was categorized with 2 or 3 groups. The variable with three groups 
consisted of no comorbidity=0, comorbidity=1 and multimorbidity=2. In the binary 
variable no comorbidity and comorbidity were collapsed into one group presenting 
multimorbidity as 0=no and 1=yes. No comorbidity was defined as the absence of the 
following diagnoses: renal failure, thyroid disease, diabetes, cardiovascular disease, 
osteoporosis, arthritis, physical impairment, cancer, stroke, asthma or chronic 
obstructive pulmonary disease. Comorbidity was defined as the presence of one of the 
diagnoses, and multimorbidity was the presence of two or more diagnoses (Guaraldi et 
al., 2014).  
• Bodily pain was computed from the pain dimension score of the Medical Outcomes 
Study 36-Item Short-Form Health Survey (SF-36). Question 21 and 22 in the SF-36 
measure physical pain during the last week on a scale from 0-100, where 100 is no pain. 
The scores were inverted and divided by ten. Bodily pain was used as a continuous 
variable on a scale from 0-10 were 0 is no pain. 
• Trouble sleeping is the question: “Do you have trouble falling or staying asleep the last 
week?”  Answered “not at all”, “a little bit”, “quite a bit” and “almost always”, and 
scored 1 to 4 respectively. The answers were recoded 1=0, 2=0, 3=1, 4=1, and presented 
as trouble sleeping 0=no and 1=yes. 
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3.2.2.3 Mental health variables 
The mental health variables are based on the Hopkins symptom checklist-25 (HSCL-25), the 
Beck’s Depression Inventory version 2 (BDI-II), the Post Traumatic Stress Scale-16 (PTSS-
16), Alcohol Use Disorder Identification Test (AUDIT) and the Drug Use Disorder 
Identification Test (DUDIT). The instruments were used to identify mental distress, depression, 
anxiety, post-traumatic stress disorder and alcohol and drug abuse. 
• HSCL-25 measures mental health based on presence of depression and anxiety 
symptoms during the last four weeks (Derogatis et al., 1974). The symptoms were 
answered “not at all”, “a little”, “quite a bit” and “extremely” and rated 1 to 4 
respectively. The total score is the mean value of all 25 questions. Separate scores were 
also calculated for anxiety and depression. The anxiety score is the mean value of the 
first 10 questions, and the depression score is the mean value of the 15 last questions. 
All HSCL-25 scores are presented as a number between 1 and 4, where 1 is no 
symptoms. A total score of 1.75 or more is defined as having mental distress (Mattisson, 
2013, Nettelbladt et al., 1993), and presented as mental distress 0=no, 1=yes.  
• All participants with a HSCL-25 total score ≥1.75 were scored again for depression with 
the BDI-II. The BDI-II consists of 21 questions and is a diagnostic tool for severity of 
depression. BDI-II divides the participants into four categories: minimal depression=1, 
mild depression=2, moderate depression=3 and severe depression=4, with cut points 
<14, 14-19, 20-29 and >29 respectively. The participants who scored <1.75 on the 
HSCL-25 were coded 0 and used as a reference group labelled “not depressed”.  
• Post-traumatic stress disorder (PTSD) was calculated from PTSS-16. The PTSS-16 
consists of 16 questions about the frequency of symptoms after stressful life experiences 
were present the last week. The answers were given as “not at all”, “a little bit”, “quite 
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a bit” and “almost always”, scored 1-4 respectively. A total mean score above 2.5 was 
defined as PTSD (Raphael et al, 1989) and presented 0=no, 1=yes. 
• The values Alcohol abuse risk and Drug abuse risk are the outcome of the Alcohol 
Use Disorder Identification Test (AUDIT) (10 questions) and the Drug Use Disorder 
Identification Test (DUDIT) (11 questions). Drugs include all kinds of substances, 
illegal or legal, that are not prescribed from a doctor. The tests calculate the risk of abuse 
the last year based on gender. The risk is given as a number between 1 to 4, where 1 is 
no risk of abuse. The variable was recoded 1=0, 2-4=1, collapsing the three risk 
categories into one group. Alcohol abuse risk and the drug abuse risk variables are 
presented as 0=no, 1=yes. 
3.2.1 Statistical analysis 
The statistics is performed in SPSS. The demographic variables were computed with 
crosstabulations and descriptive analysis. The variables are presented in Tables 1-3 as means 
(M) with standard deviation (SD) or total numbers with percentages.  
The Odd Ratios (OR) were calculated using logistic regression. The crude ORs were calculated 
with univariate analysis entering the independent variables separately against the dependent 
variable. For the adjusted OR (aOR), all the covariates were entered into the regression model 
at the same time.  
To identify the regression model with the best model fit, all the potential variables were added 
as covariates and run in a backward model with 0.10 percent probability of stepwise removal. 
Five covariates (living alone, high education, bodily pain, multimorbidity and mental distress) 
became significant at a 5% level and were kept in the analysis. Then the other variables were 
re-entered and removed several times while checking for changes in the model summary and 
the Hosmer and Lemeshow test, ending up with ten covariates representing the socio-
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demographic, mental health, HIV and other health related characteristics. In the final regression 
model, the dependent variable fatigue is binary, three independent variables are continuous; 
age, CD4+ count and bodily pain, and seven are dichotomous; gender, living alone, high 
education, MSM, multimorbidity, mental distress and trouble sleeping.  
The ORs and the aORs are presented with 95% Confidence Intervals (CI) and p-values. All 
significance levels are set at <0.05. Correlations were checked for in the correlation matrix and 
in the collinearity statistics. The number of residuals above 2 were less than 5%. Cook’s 
influence statistics showed one outlier with levels higher than 1, and a closer look displayed 
large discrepancies in the answers and the outlier was removed from the analysis.  
3.2.2 Missing data 
Four participants did not give information about the duration of fatigue. In Table 1, the variable 
work status has two missing, and in Table 3, PTSD has one missing and BDI-II has two missing. 
All the missing variables were from fatigued participants. Variables with missing data in Tables 
1 and 3 are marked with a *. The final regression model does not contain any missing data.  
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4 Results 












As shown in Figure 1, a total of 121 patients from the Hospital of Southern Norway (SSHF) 
and 158 patients from the University Hospital of North Norway (UNN) were registered at the 
out-patient clinics between December 2014 and September 2015 (n=279). 10 patients were 
excluded due to severe mental disorders or cognitive impairment. 14 declined to participate for 
various reasons and 10 people were not asked to participate or did not have contact with the 
hospital during the recruitment period. Of the 279 patients registered at the hospitals, 245 
completed the survey, which gives a response rate of 87.8%. One outlier was later removed and 
a total of 244 patients were included in the analysis. 
Patients included 
(n=245) 
Outlier removed (n=1) 
Fatigued  
(n=94) 
Patients assessed for 
eligibility (n=279) 
Excluded due to: 
-severe mental disorder /       
cognitive impairment (n=10)  
-declined to participate (n=14) 
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4.1 Prevalence and demographic characteristics 
The prevalence of fatigue among the participants was 38.5%, as 94 out of 244 of the participants 
scored 4 or more on the FQ. Chronic fatigue was seen in 44 of the fatigued cases (18% of all 
participants, 4 missing). Increased time since onset of fatigue symptoms was related to fatigue 
intensity; as all mean FQ total bimodal scores increased with time. The chronic fatigued 
participants had the highest FQ total score with a mean of 7.36 (SD=2.06). (Appendix Table 
5). 
The socio-demographic characteristics are presented in Table 1 and display similar distribution 
of age, gender and native countries between the two hospitals, but some differences were seen 
in work status, education, cohabitation and fatigue. 
The participants were between 18 and 77 years old, had a mean age of 43.7 years (SD=11.7) 
and the average time since diagnose was 9.36 years (SD=7.39). 46.7% of the participants were 
women and 53.3% were men. Only 32.8% of the participants were born in Norway, the other 
were immigrants. The largest immigrant group was from Africa (n=100), and four countries 
had more than ten immigrants each; Eritrea, Ethiopia, Somalia and Thailand.  
Half of all the Norwegians and South-Americans were fatigued, whereas 1 in 3 of the 
Europeans, Asians and Africans were fatigued. Overall, the gender distribution differed among 
the native countries; there were more women from Asia and Africa and more men from 
Norway, Europe and South-America. The prevalence of fatigue was higher among the 130 
males (43.1%) than the 114 females (33.3%), and 58% of the MSM were fatigued (n=31). MSM 
were more likely to be Norwegian (71%), highly educated (74%), living alone (80%) and 
mentally distressed (52%) compared to the mean distribution, whereas women were more likely 
to be immigrants (68%), have low education (70%), cohabitate (56%) and not mentally 
distressed (73%). Fatigued participants were older than the non-fatigued (M=45.2, SD=11.9 vs 
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M=42.8, SD=11.6), were more likely to live alone (69.1% vs 41.3%) and to have high education 
(48.9% vs 37.5%). The participants were asked about their work status; 35.1% reported working 
full time, 11.6% reported unemployment and 11.6% were disabled pensioners, 11.1% were 
students or participants in the Norwegian introduction course (the other categories are displayed 
in Appendix Table 6).  The disabled pensioners (64%) and the unemployed (40%) were more 
fatigued than the full-time employed (28%) and the students (22%). Attempts were made to 
regroup the work status variables in the preliminary analysis (data not shown), but none of the 
work status categories were kept in the regression model. The distribution of immigrants and 
education level differed between the work status groups, especially between the two groups 
with high level of fatigue; the unemployed had 93% with low education and 93% immigrants, 
and the disabled pensioners had 54% with low education and 32% immigrants.   
 





Table 1. Sociodemographic characteristics of the study sample (N=244)   
























Participants, N (%) 244 150 (61.5) 94 (38.5) 135 (55.3) 109 (44.7) 114 (46.7) 130 (53.3) 
Age (y), mean (SD) 43.7 (11.7) 42.8 (11.6) 45.2 (11.9) 44.3 (11.9) 43.1 (11.5) 41.7 (10.7) 45.5 (12.3) 
Hospital N (%)        
  UNN 135 (55.3) 89 (59.3) 46 (48.9)   63 (55.3) 72 (55.3) 
  SSHF 109 (44.7) 61 (40.7) 48 (51.1)   51 (44.7) 58 (44.7) 
Gender, N %        
  Female 114 (46.7) 76 (50.7) 38 (40.4) 63 (46.7) 51 (46.7)   
  Male 130 (53.3) 74 (49.3) 56 (59.6) 72 (53.3) 58 (53.2)   
Cohabitation, N (%)        
  Living together 117 (48) 88 (58.7) 29 (30.9) 72 (52.6) 45 (41.3) 64 (65.1) 53 (40.8) 
  Living alone 127 (52.0) 62 (41.3) 65 (69.1) 63 (47.4) 64 (58.7) 50 (43.9) 77 (59.2) 
Education, N (%)        
  Low education 142 (58.2) 94 (62.7) 48 (51.1) 71 (52.6) 71 (65.1) 80 (70.2) 62 (47.7) 
  High education 102 (41.8)  56 (37.5) 46 (48.9) 64 (47.4) 38 (34.9) 34 (29.8) 68 (52.3) 
Work status, N* (%)        
  Working full time 85 (35.1) 61 (40.7) 24 (26.1) 56 (41.5) 29 (27.1) 36 (32.1) 49 (37.7) 
  Unemployed 28 (11.6) 17 (11.3) 11 (12.0) 13 (9.6) 15 (14.0) 16 (14.3) 12 (9.2) 
  Disable pensioner 28 (11.6) 10 (6.7) 18 (19.6) 11 (8.1) 17 (15.9) 11 (9.8) 17 (13.1) 
  Student 27 (11.2) 21 (14) 6 (6.5) 17 (12.6) 10 (9.4) 15 (13.4) 12 (9.2) 
  Other 74 (30.6) 41 (27.3) 33 (35.9) 38 (28.2) 36 (33.6) 34 (30.4) 40 (30.8) 
Native country, N (%)        
  Norway 80 (32.8) 40 (26.7) 40 (42.6) 46 (34.1) 34 (31.2) 16 (14.0) 64 (49.2) 
  Europe 16 (6.6) 11 (7.3) 5 (5.3) 8 (5.9) 8 (7.3) 6 (5.3) 10 (7.7) 
  South-America 10 (4.1) 5 (3.3) 5 (5.3) 5 (3.7) 5 (4.6) 1 (0.9) 9 (6.9) 
  Asia 38 (15.6) 25 (16.7) 13 (13.8) 22 (16.3) 16 (14.7) 29 (25.4) 9 (6.9) 
  Africa 100 (41.0) 69 (46.0) 31 (33.0) 54 (40.0) 46 (42.2) 62 (54.4) 38 (29.2) 
SD: standard deviation  
UNN: University hospital of North Norway 
SSHF: Hospital of Southern Norway 
*N=242, 2 missing fatigued female cases from SSHF 
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As seen in Table 2, the participants were well treated with 93% on ART, 94% were virus 
supressed after 6 months of treatment and mean levels of CD4+ T Lymphocytes at 0.50 (x109/L) 
(SD=0.26). There was a small difference between fatigued and non-fatigued cases regarding 
treatment failure with 6% versus 5.5% respectively. A large proportion (43.9%) reported 
“unknown” as transmission route, and not knowing the route of transmission was more frequent 
among females (51%) than males (37%). Only one participant reported needle sharing as 
transmission route (Appendix Table 7). Overall 7.4% were at risk of drug abuse, but the number 
of intravenous drug users or previous users were not established. Both alcohol abuse risk 
(18.1% vs 12.0%) and drug abuse risk (13.8% vs 3.3%) were higher among the fatigued than 
the non-fatigued. Alcohol risk abuse did not contribute to the regression model, whereas drug 
risk abuse had an impact. Having risk of drug abuse increased the risk of fatigue, but was left 
out of the final regression model due to poorer fit than the variable trouble sleeping. Trouble 
sleeping was present in 25% of all participants and 50% of the fatigued. There were more 
participants with multimorbidity among the fatigued (13.8%) than the non-fatigued (5.3%), but 
having only one comorbidity showed the opposite relationship (11.7% vs 14%). Hepatitis C 
antibody (13.8%) and anaemia (10.6%) were more frequent among the fatigued than the non-
fatigued (10% and 8.7%, respectively). Hepatitis C and anaemia were added in the comorbidity 
variable at one point, but later removed as it did not contribute to the model. The fatigued 
experienced more pain than the non-fatigued; on a scale from 0-10, in which 0 indicates no 
pain, the non-fatigued had a mean score of 1.69 (SD=2.21) and the fatigued had a mean score 
of 4.90 (SD=5.50). 
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Table 2. HIV and health related characteristics of the study sample (N=244)  
Mental health and quality of life among people living with HIV in Northern and Southern Norway, 2014-2015 
 
Characteristics 







Time since diagnose, mean (SD) 9.36 (7.39) 9.15 (6.85) 9.7 (8.22) 
Transmission route, N (%)    
    Heterosexual 97 (39.8) 62 (41.3) 35 (37.2) 
    Men who have sex with men 31 (12.7) 13 (8.7) 18 (19.1) 
    Other 9 (3.7) 5 (3.3) 4 (4.3) 
    Unknown 107 (43.8) 70 (46.7) 37 (39.4) 
Antiretroviral therapy, N (%) 227 (93.0) 138 (92.0) 88 (93.6) 
Virus suppressed, N (%) 211 (86.5) 130 (86.7) 81 (86.2) 
Treatment failure, N* (%)  12 (5.7) 7 (5.5) 5 (6.0) 
CD4+ (x109/L), mean (SD) 0.53 (0.26) 0.54 (0.29) 0.52 (0.22) 
Hepatitis C antibody, N  28 (11.5) 15 (10.0) 13 (13.8) 
Anemia, N (%) 23 (9.4) 13 (8.7) 10 (10.6) 
Comorbidity, N (%)    
    No comorbidity 191 (78.3) 121 (80.7) 70 (74.5) 
    Comorbidity 32 (13.1) 21 (14.0) 11 (11.7) 
    Multimorbidity 21 (8.6) 8 (5.3) 13 (13.8) 
Bodily pain, mean (SD) 2.93 (2.96) 1.69 (2.21) 4.90 (5.50) 
Trouble sleeping, N (%) 63 (25.8)  16 (10.7) 47 (50.0)  
SD: standard deviation; CD4+: T–lymphocyte cell bearing CD4+ receptor    
*participants on antiretroviral treatment >6 months (N=212)  
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The mental health characteristics presented in Table 3 display a clear link between mental 
health and fatigue; 64.9% of the fatigued participants and only 10.6% of the non-fatigued 
participants had mental distress. All the three HSCL-25 mean scores (scale 1-4) were higher 
among the fatigued than the non-fatigued, which indicates higher levels of both anxiety (M=1.9, 
SD=10.32 vs M=1.29, SD=0.60) and depression (M=2.21, SD=0.67 vs M=1.40, SD=0.36) 
among the fatigued. The association between depression and fatigue was seen for all BDI-II-
scores and none of the non-fatigued were severely depressed. All participants with PTSD 
(n=15) were severely depressed (N=19). Due to the strong relationship between PTSD and 
severe depression, PTSD was left out of the regression model. The analysis was at one point 
run without the severely depressed participants, but the main results remained unchanged and 
the severely depressed were kept in the equation (data not shown).    
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Table 3: Mental health characteristics of the study sample (N=244) 














Hopkins Symptoms Checklist-25, mean (SD)    
    Total Score 1.64 (.58) 1.35 (.32) 2.09 (.60) 
    Anxiety score 1.53 (.54) 1.29 (.32) 1.91 (.60) 
    Depression score 1.71 (.64) 1.40 (.36) 2.21 (.67) 
Mental distress, N (%) 77 (31.5) 16 (10.6) 61 (64.9) 
Beck’s Depression Inventory, N* (%)    
    Not depressed 167 (69.0) 134 (89.3) 33 (35.9) 
    Minimal depression 16 (6.6) 5 (3.3) 11 (12.0) 
    Mild depression 25 (10.3) 7 (4.7) 18 (19.5) 
    Moderate depression 15 (6.2) 4 (2.7) 11 (12.0) 
    Severe depression 19 (7.9) 0 (0) 19 (20.6) 
Post-Traumatic Stress Disorder, N* (%) 15 (6.1)  0 (0) 15 (16.1)  
Drug abuse risk, N (%) 18 (7.4) 5 (3.3) 13 (13.8) 
Alcohol abuse risk, N (%) 35 (14.3) 18 (12.0) 17 (18.1) 
SD: standard deviation 
*BDI-II: N=242, 2 missing fatigued cases 
*PTSD: N=243, 1 missing fatigued case 
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4.2 Predictors of fatigue 
The results from unadjusted and adjusted analyses are presented in Table 4. All ten variables 
(age, gender, cohabitation, high education, MSM, CD4+ count, multimorbidity, bodily pain, 
mental distress and trouble sleeping) independently contributed to the regression model as 
predictors or confounders. The model performed well with sig .953 for The Hosmer and 
Lemeshow Test and Omnibus Test of model Coefficients Chi-square of 144.045 (χ2 (10, 
N=244) = 114.045, p < .000). The model summary implied that between 44.8% and 60.9% of 
the variability is explained by the model. 
Five out of ten covariates in the final regression model were significantly associated with 
fatigue. Mental distress had an aOR of 8.98 (aOR 8.98, 95% CI 3.81-21.15), indicating that 
patients with a HSCL total score above 1.75 were almost nine times more likely to report 
symptoms of fatigue than those not fatigued. Mental distress had the highest aOR among the 
dichotomous variables. A significant result was also seen when the HSCL-25 total score was 
used as a continuous variable (OR, 45.44, 95% CI 16.89-122.22) (range 1-4), but the variable 
had a large confidence interval due to high impact on the model from the severely depressed, 
and the binary variable was preferred in the model. Having bodily pain was associated with 
fatigue with an aOR of 1.44 per increase in pain score (range 0 to 10) (aOR 1.44, 95% CI 1.25-
1.67), indicating that the likelihood of fatigue increases with the severity of pain. Bodily pain 
(Wald 24.99) and mental distress (Wald 25.21) contributed most to the predictive ability of the 
model as they both had three times as high Wald statistics than the third highest covariate living 
alone (Wald 7.43). Bodily pain and mental distress had p-values less than .001 in both the crude 
and the adjusted analysis.  
The three other significant predictors of fatigue were living alone (aOR 2.99, 95% CI 1.36-
6.56), trouble sleeping (aOR 2.67, 95% CI 1.06-6.71) and multimorbidity (aOR 5.13, 95% CI 
1.25-21.15). High education was significantly related to increased fatigue in the backward 
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analysis (data not shown), but the relationship was neither significant in the unadjusted (OR 
1.58, 95% CI 0.94-2.66) nor the adjusted analysis (aOR 2.15, 95% CI 0.95-4.87). 
Age, gender and MSM were re-entered in the regression model as confounding factors as they 
contributed positively to the model fit. Being male shifted from increased risk (OR 1.45, 95% 
CI 0.89-2.51) to decreased risk of fatigue after adjustment (aOR 0.82, 95% CI 0.35-1.95). The 
relationship between gender and fatigue remained non-significant. The variable MSM had 
significant crude OR (OR 2.51, 95% CI 1.17-5.41), but it became non-significant after 
adjustment (aOR 1.43, 95% CI 0.38-5.23).  
None of the HIV-related variables were significantly associated with fatigue, only CD4+ count 
contributed enough to the final regression model to be selected. Low CD4+ count was 
negatively associated with presence of fatigue, and got a narrower CI after adjustment (aOR 
0.90 95% CI 0.78-1.04), but the association remained non-significant.  
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Table 4. Logistic regression of factors associated with fatigue (N=244) 
Mental health and quality of life among people living with HIV in Northern and Southern Norway, 2014-2015 
  
 
crude Odds Ratio  
 
adjusted Odds Ratio  
OR 95% CI p  aOR 95% CI p 
Age 1.02 (0.99 - 1.04) .120  1.01 (0.98 - 1.05) .515 
Male gender 1.49 (0.89 - 2.51) .131  0.82 (0.35 – 1.94) .654 
Living alone 3.18 (1.84 - 5.49) .000*  2.99 (1.36 - 6.56) .006* 
High education 1.58 (0.94 – 2.66) .085  2.15 (0.95 – 4.87) .068 
MSM 2.51 (1.17 - 5.41) .018*  1.43 (0.39 - 5.23) .586 
CD4+ (x109/L)  0.97 (0.88 – 1.07) .514  0.90 (0.78 - 1.04) .179 
Multimorbidity 2.85 (1.13 – 7.16) .026*  5.13 (1.40 - 18.73) .013* 
Bodily pain 1.54 (1.37 - 1.73) .000*  1.44 (1.25 - 1.67) .000* 
Mental distress 15.48 (7.93 - 30.24) .000*  8.98 (3.81 - 21.15) .000* 
Trouble sleeping 8.38 (4.34 – 16.16) .000*  2.67 (1.06 - 6.71) .037* 
aOR: all scores in logistic regression with 10 covariates (age, gender, cohabitation, high education, MSM, CD4+ count, 
multimorbidity, bodily pain, mental distress and trouble sleeping) are shown in this table. 
Age: OR per 1year increase (scale 18-77); CD4+ (x109/L): OR per 0.10 increase (scale 0.01-1.83); bodily pain: OR per 
1-unit increase (scale 0-10). 
OR: crude Odds Ratio; aOR: adjusted Odds Ratio; CI: Confidence Interval; MSM: men who has sex with men; CD4+: 
T–lymphocyte cell bearing CD4+ receptor 
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5 Discussion 
This is to our knowledge the first Norwegian study on HIV-related fatigue. Using FQ, the 
prevalence of fatigue among PLWH in Northern and Southern Norway is 38.5%.  The strongest 
predictors of fatigue are mental distress and bodily pain. Other significant predictors are living 
alone, trouble sleeping and multimorbidity.  
5.1 Prevalence of fatigue 
A fatigue prevalence of 38.5%  among PLWH is in the low range of previously reported study 
findings (Jong et al., 2010). This may be explained by free access to high quality health care 
services and other social support systems in Norway. In addition, this study was not performed 
by self-referral as all the participants were recruited trough the hospitals, and a high response 
rate indicated that both the fatigued and the non-fatigued were included. It is expected that those 
excluded have a higher fatigue rate than the included since one of the exclusion criteria was 
severe mental disorders which are associated with fatigue. Only ten patients were excluded due 
to severe mental disorders or cognitive impairment and would therefore not make a large 
contribution to the fatigue prevalence if included. There is no indication that those who declined 
or otherwise did not participate were more fatigued than the included participants.  
Fatigue is described as persisting in the literature (Pence et al., 2009), and a longitudinal study 
from 2014 showed little variability among the fatigued; those who entered the study most 
fatigued remain fatigued during the 3-year follow-up (Barroso et al., 2014). Long standing 
fatigue symptoms are also seen in our study as chronic fatigue was seen in 44% of all fatigued 
cases. The chronic fatigued had higher fatigue intensity than those fatigued less than six months; 
the CFS mean values increased with the duration of fatigue. This indicates a higher intensity of 
fatigue with time, which is consistent with previous findings (Barroso et al., 2014; Pence et al., 
2009). Loge and colleagues (1998) assessed fatigue in the general Norwegian population in 
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1997, with the use of the same instrument as in our study (FQ) which makes it easier to compare 
the two studies. They found that 22% scored 4 or more on the FQ and 11% were chronically 
fatigued (n=2287), which is nearly half of what was found in our study (38.5% and 18%, 
respectively). Both the Norwegian general population and the Norwegian PLWH have fatigue 
prevalence in the low range of international studies, but fatigue among PLWH should still be 
recognised as a common and persisting symptom.  
5.2 Demographic findings and predictors of fatigue 
This study identified five significant predictors of fatigue; mental distress, bodily pain, living 
alone, trouble sleeping, and multimorbidity. The strongest predictors are mental distress due to 
high aOR compared with the other dichotomous variables, and bodily pain with a dose response 
for each increase in pain score. ORs obtained for continuous and dichotomous variables cannot 
be directly compared. However, due to the observed consistency throughout all the preliminary 
analyses, high ORs and the large impact on the final regression model, we recognise mental 
distress and bodily pain to be the strongest predictors of fatigue among PLWH. 
Mental distress is depression and anxiety symptoms measured with the HSCL-25. Higher mean 
scores were seen for both the anxiety and the depression values in Table 2. The mean depression 
value was higher than the mean anxiety value, but it is not possible to say whether it is anxiety 
or depression that is most related to fatigue since the two symptoms often are present in the 
same individual. A strong relationship between mental distress and fatigue is in accordance 
with previous findings (Barroso et al., 2010; Jong et al., 2010; Barroso and Voss, 2013). Mental 
distress is a common symptom as nearly 1/3 of all participants and 2/3 of the fatigued 
participants had symptoms of anxiety and depression. However, higher depression rates have 
been found in international studies (Noh et al., 2012; Whetten, 2008; Rodkjaer et al., 2010).  A 
Danish study found that 38% had BDI-II score >14 (n=207) (Rodkjaer et. al., 2010). Our study 
found that 24% had a BDI-II score >14. This lower depression prevalence mirrors the lower 
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fatigue prevalence which already is discussed. PLWH have often experienced traumatic events 
(Corless et al., 2013; Whetten, 2008). In our study all participants identified with PTSD had 
severe depression and fatigue, so there is a clear link between the three variables. It is not 
possible to establish any causality between fatigue and depression due to the cross-sectional 
study design. Fatigue can be both a cause and a symptom of depression at the same time. 
Barroso and colleagues (2010) demonstrated that changes in depression indicated changes in 
fatigue during a one-year follow-up, and that providing coping strategies for depression, better 
sleep hygiene and increased physical activity led to a decrease in fatigue intensity among 
PLWH (Barroso et al., 2010; Barroso et al., 2016). Identifying and treating depression are 
important when assessing fatigue treatment strategies.  
Pain as a predictor for HIV-related fatigue has been less investigated than depression, and was 
one of the factors warranted for further research by Loades and Kagee (2017). Wilson (2016) 
identified muscle aches/joint pain (and sleep difficulty), as the most prevalent and most 
bothersome symptoms among PLWH, whereas abdominal pain and numbness/pain in the feet 
were less prevalent, but bothersome. The underlying causes for the experienced pain were not 
assessed in our study. Still, the association between fatigue and pain was so strong that pain 
should be used as a variable in future research on fatigue.  
In our study, trouble sleeping was identified as a predictor of fatigue. The variable was based 
on one question, which gives little information about the type of difficulty the participants 
experienced, whether it was insomnia and/or sleep insufficient from reduced quantity or quality 
of sleep. There are many causes and consequences of sleep disturbances, associations to 
psychiatric disorders, use of ART, pain and several medical conditions are known (UptoDate, 
Chirelli, C., 2018). Future research with a validated instrument which assesses different aspects 
of sleep disturbance might give more information about the relationship between fatigue and 
type of sleep disturbance. 
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Multimorbidity was seen in only 13 fatigued cases. This is reflected in a large confidence 
interval, but the variable had an independent impact on the regression model and a lower p-
value after adjustment. There are some uncertainties about this variable. The definitions of 
comorbidity and multimorbidity could have been done differently, but entering hepatitis and 
anaemia into comorbidity in the preliminary analysis did not change the result. Our study found 
that participants diagnosed with one other chronic disease were less fatigued, but two or more 
diseases were associated with fatigue. Corless and colleagues (2008) showed a relationship 
between the number of comorbidities and fatigue severity, but they included hepatitis and 
depression as comorbidities. Since depression is such a strong predictor of fatigue, including 
depression in the comorbidity variable, like in the previously mentioned study, would have 
changed the results of the comorbidity/multimorbidity variable in our study. The comorbidities 
chosen in our study are based on a review from Guaraldi and colleges (2014) on multimorbidity. 
They list anaemia as a comorbidity, but not hepatitis and depression. There is a large ongoing 
study in Denmark on HIV and comorbidities (Ronit et al., 2016) that might contribute to a 
standardisation of the comorbidity definitions in PLWH in the future. 
Females are found to be more fatigued than men in the healthy population (Akerstedt et al., 
2004; Engberg et al., 2017). In our study, males are more fatigued before adjustment, but after 
adjustment female predicted fatigue, although the results were non-significant. Gender 
differences were seen; males were older, more likely to have high education, live alone and be 
born in Norway. These are variables with high numbers of fatigued participants in the 
sociodemographic table. The prevalence of fatigue among MSM was high, and reporting MSM 
was significantly associated with fatigue in the univariate analysis. After adjusting for the other 
covariates, MSM was no longer significant. The MSMs were more likely to live alone, have 
high education and have mental distress than the mean, which all were adjusted for in the 
multivariate analysis. There are uncertainties about the number of MSM measured in this study, 
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and the number of MSM was low compared to the registered MSMs in MSIS.  On one hand the 
Norwegian surveillance system reported a higher percentage of MSM, so it is likely that there 
are MSMs among the participants reporting “unknown” as transmission route and this could 
affect the prevalence of fatigued MSM in our study. On the other hand, the number of 
“unknown” was higher among the females than the males, indicating that many people do not 
know how they got HIV (or are reluctant to tell), not only the MSM. A question like: “Did you 
have sex with someone of your own sex, in the period of assumed HIV-transmission?” might 
have been a better measurement of MSM. Being MSM and HIV-positive is characterised as 
living with a double stigma; first that of being gay and then that of being HIV-positive (Gibbie 
et al., 2012). This double burden might explain the high prevalence of mental distress and 
fatigue displayed.  
Low CD4+ counts are associated with high risk of opportunistic infections since the immune 
system is weakened. The relationship between CD4+ count and fatigue in our study goes toward 
a lower fatigue among those with high CD4+ count in the adjusted analysis, but the result was 
not significant. We did not establish any significant associations between any of the HIV-
related factors and fatigue. International literature describe conflicting results concerning the 
associations between fatigue and time since diagnosis, CD4+ count and virus suppression (Jong 
et al., 2010).  
Depression and sleep disturbance are associated with treatment failure (Huynh et al., 2013). 
Gay and colleagues (2011) list treatment of fatigue as a strategy to improve ART-adherence, 
and a systematic review from 2014 found a relationship between low ART-adherence and 
presence of fatigue. We found only a small difference in treatment failure in the fatigued group 
(5.5%) compared to the non-fatigued (6.0%), and we cannot conclude that fatigue is associated 
with poor ART-adherence. Possible explanations might be that our study population is well 
treated due to close follow-up by the health care system, combined with improvements in ART 
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the last years, such as less side-effects and easier complacence due to one tablet regimes.  It is 
possible that fatigued patients would have had poorer adherence if they had to make a larger 
effort to access the medications. 
Other studies have identified unemployment as a risk factor for fatigue. Disabled pensioners 
and unemployed were more fatigued than students and those who work full-time, but work 
status did not contribute to the regression model and our study was not able to establish any 
significant relationship between fatigue and any of the work status answers. The disabled 
pensioners were most fatigued, which can be explained by the same reason they became 
disabled, but these reasons are not known. There are social support systems in Norway for the 
unemployed and for disabled pensioners, but the amount of received payment is set based on 
previous income. Inadequate income has been associated with fatigue (Jong et al., 2010), but 
there was no information about income in this study, and such information might have 
contributed to a relationship between income, work status and fatigue. Work status was also 
linked to education. Only two participants with high education were unemployed. High 
education was associated with fatigue, but the association was not statistically significant. The 
opposite result was found in a study of the general Swedish population, where high education 
was associated with low fatigue intensity (Engberg et al., 2017). The correlation between high 
education, work status, native country and gender might influence the results for high 
education, especially since there was no adjustment for native country and work status in the 
multivariate analysis.  
5.3 Strengths and limitations 
The study had a cross-sectional design and it is therefore impossible to establish any causality 
between the presented predictors and the dependent variable. There were limitations to the 
number of variables which could be entered into the final regression model, as we had only 244 
participants. Some estimates have large confidence intervals due to a small sample size. With 
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more participants and greater power, some variables, such as high education and drug abuse, 
might have become significant. To limit the risk of confounding, all the variables in the final 
regression model were adjusted for, and the variables were based on previous known 
confounders and predictors. Drug-abuse was the last variable to be removed from the final 
regression model and is therefore not adjusted for, but the removal did not change the result of 
the other predictors. Another potential confounder is physical activity, a variable associated 
with reduced fatigue (Webel et al., 2016; Barroso et al., 2016), but our survey did not include 
information about this variable.  
The survey’s strengths include the high response rate, few excluded participants and no missing 
variables in the regression. The inclusion of non-speaking Norwegians and people with poor 
reading and writing skills improves the external validity as the study sample is close to the 
target population. To avoid bias in translation for the non-Norwegian/English speaking 
participants, the interpreters had received the survey via mail in advance, and the same 
interpreters were used in both hospitals. The interviews were standardized, and the three nurses 
who performed the interviews were instructed to respond in the same manner if the participants 
wanted further explanations about the questions. Validated instruments were used when 
possible to increase the reliability and the possibility to compare the findings with existing 
literature. Questionnaires always introduce a risk of recall bias. Our questions were about events 
and symptoms in the last week, last month or last year. Most of them were about the last week, 
a relative short time period to remember. The only question related to events from more than a 
year ago was transmission route. The question yielded several answers in the category 
unknown. 
The socio-demographic variables differed little between the two hospitals, and it is likely that 
the demographics reflect the situation in medium sized hospitals in Norway. The group of 
PLWH followed up in OUS has a larger percentage of MSM and injecting drug users than the 
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rest of Norway, and therefore the fatigue prevalence might be somewhat higher in that 
geographic area. However, the predictors should be similar in all parts of Norway since the 
symptoms that explain fatigue are the same. There are some uncertainties about the validity of 
the background prevalence, since the study was performed 20 years ago. 
The results in this study are relevant to health care providers. Fatigue is a common symptom 
which is rarely addressed in the clinical daily routine. If fatigue and its predictors, like mental 
distress and bodily pain, are identified and addressed, it may improve the quality of life for the 
individual patient. More research on prevention and treatment strategies for fatigued PLWH is 
needed, and should be implemented in the daily clinical routines. Hopefully, the present study 
can improve the situation for this vulnerable patient group, which is subject to considerable 
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6 Conclusion 
Symptoms of fatigue are common among PLWH in Northern and Southern Norway. The 
prevalence of 38% is almost two times higher than the estimated prevalence in the general 
Norwegian population (22%). Fatigue intensity increases over time and is the most pronounced 
in the chronically fatigued. Since chronic fatigue is seen in 44% of the fatigued PLWH, fatigue 
must be recognised as a persisting symptom. In our study, mental distress, such as anxiety and 
depression, and bodily pain were identified as the strongest predictors of fatigue. Other 
significant predictors were trouble sleeping, living alone and multimorbidity. None of the HIV-
related factors assessed were associated with fatigue, and we did not find poorer ART-
adherence among fatigued participants. PLWH live longer due to highly effective ART, and 
improving their quality of life is important. If fatigue and its predictors, like mental distress and 
bodily pain, are identified and addressed, it may improve the quality of life for many. More 
research on prevention and treatment strategies for fatigued PLWH is needed, and should be 
implemented in the daily clinical routines. 
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8 Appendix 
 
Table 5: Duration of fatigue vs intensity of fatigue (N=244) 
  
Chalder fatigue scale bimodal score 






0 150 0.78 (1.06) 0 
<1 week 7 6.14 (1.86) 5 
<3 months 25 6.68 (2.29) 6 
3-6 months 14 7.07 (1.77) 7 
>6 months 44 7.36 (1.99) 8 
Missing 4 5.75 (2.06) 5.5 
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Table 6: Work status vs fatigue and education (N=242) 



















Full-time job 85 61 24 39 46 
Student 27 21 6 15 12 
Pensioner 15 9 6 6 9 
Part-time job 10 8 2 8 2 
Part-time job / Sick leave 3 3 0 2 1 
Part-time job / Unemployed 10 4 6 7 3 
Part-time job / Disabled 
pensioner 
6 5 1 5 1 
Sick leave 10 5 5 6 4 
Unemployed 28 17 11 26 2 
Medical rehabilitation 1 1 0 1 0 
Occupational rehabilitation 17 5 12 9 8 
Disabled pensioner 28 10 18 15 13 
Maternity leave 2 1 1 1 1 




Page 3 of 20 
Table 7: Transmission route by gender vs fatigue (N=244) 















Heterosexual 44 30 14 
MSM 31 13 18 
Blood transfusion 5 3 3 
Needle sharing 1 0 1 
Unknown 49 28 21 






Heterosexual 53 32 21 
Blood transfusion 2 1 1 
Perinatal 1 1 0 
Unknown 58 42 16 
Total 114 76 38 
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 Sjekkliste studievariabler  Dato:   
     Svar   
 Nummer        
 Kjønn        
 Fedreland        
 Statsborgerskap      
  Asylsøker        
  Flyktning med opphold       
  Innvandrer -ikke vestlig       
  Innvandrer -vestlig       
  Statsborgerskap       
 Sivilstand       
  Enslig        
  Gift        
  Samboer        
  Skilt        
  Enke(mann)       
 Utdannelse Antall år       
 Arbeidsforhold      
  Jobb; fulltid -deltid       
  Sykemeldt        
  Medisinsk rehabilitert       
  Arbeidavklaringspenger       
  Arbeidsledig       
  Uføretrygdet       
  Pensjonert        
  Student        
  Fødselspermisjon       
  Pappapermisjon       
  Jobb deltid -sykemeldt       
  Jobb deltid -arbeidsledig       
  Jobb deltid -uføretrygdet       
 Mentalhelse og mestring      
 Henvist til psykiatrisk behandling JA           NEI    
 Har/har hatt psykiatrisk behandling JA           NEI    
 Har læring- og mestringskurs  JA           NEI    
 Har individuellplan  JA           NEI    
 Har barn   JA           NEI    
 Hvis ja_Bor med egne barn  JA           NEI    
 Informert sine nærmeste om diagnosen JA           NEI    
 Åpen om sin diagnose  JA           NEI    
         
 Røyker   ja            nei    




Smittemåte        
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 Heteroseksuell         
 Homoseksuell/MSM        
 Sprøytemisbruk         
 Blodtransfusjon        
 Medfødt        
 Ukjent       
         
 Hentes fra DIPS      
  T4        
  HIV-RNA        
  Hb        
  Na        
  K        
  Ca        
  PTH        
  kreatinin        
  vit-D 25-OH       
  ASAT        
  ALAT        
  T8-celler        
  hepatitt C antistoff        
  hepatitt B surface antigen        
 
 






       
 Resistens  Kryss      
  Anivirale komb       
  Proteasehemmere       
  NRTI        
  NNRTI        
  Andre antivirale midler       
  Integrasehemmere       
  Ingen resistens påvist       
         
 CDC Kategori A       
  Kategori B       
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•               Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): 
              a self-report symptom inventory. Behav Sci. 1974 Jan;19(1):1-15. 
              Forskningsenhet for kontrollerte kliniske forsøk i nasjonalt ryggnettverk 
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PTSS-16 
De følgende spørsmålene handler om symptomer som folk kan ha etter skremmende og voldsomme 
begivenheter. Nå stiller vi deg noen spørsmål om slike symptomer. Kan du si hvor mye du selv har vært plaget 
av slike symptomer i den siste uken? 
























1. Tilbakevendende tanker eller minner om de skremmende  0 1 2 3 
og voldsomme hendelsene? 
2. Følt som om du opplever hendelsen igjen?    0 1 2 3 
 
3. Tilbakevendende mareritt om begivenhetene?   0 1 2 3 
 
4. Føler deg isolert fra andre mennesker?    0 1 2 3 
 
5. Er ute av stand til å føle noe ordentlig?    0 1 2 3
    
6. Blir lett forskrekket, spesielt skvetten?    0 1 2 3 
 
7. Har vanskeligheter med å konsentrere deg    0 1 2 3 
 
8. Har søvnproblemer?      0 1 2 3 
 
9. Føler at du er på vakt?      0 1 2 3 
 
10. Føler deg irritabel eller blir fort sint?    0 1 2 3 
 
11. Unngår aktiviteter som minner deg om de ubehagelige og  0 1 2 3 
voldsomme hendelsene? 
12. Vært ute av stand til å huske deler av de voldsomme    0 1 2 3 
hendelsene? 
13. Vært mindre interessert I dagligdagse aktiviteter?   0 1 2 3 
  
14. Føler som om du ikke har noen fremtid?    0 1 2 3 
 
15. Unngår tanker og følelser som er forbundet med de   0 1 2 3 
ubehagelige og voldsomme hendelsene? 
16. Hatt plutselige følelsesmessige eller kroppslige reaksjoner  0 1 2 3 
når du blir minnet om det som skjedde? 
 
 
Raphael B, Lundin T, Weisaeth L. A research method for the study of psychological and psychiatric aspects of disaster. Acta 
Psychiatr Scand Suppl 1989; 353: 1 – 75. 
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BDI-II  
 
Velg det utsagnet i hver gruppe som best beskriver hvordan du har følt deg i løpet av de to siste ukene. 
 
1. 0 Jeg føler meg ikke trist 
1 Jeg føler meg trist store deler av tiden 
2 Jeg føler meg trist hele tiden 
3 Jeg er så trist og ulykkelig at jeg ikke holder det ut 
 
2. 0 Jeg er ikke motløs med tanke på fremtiden 
 1 Jeg er mer motløs med tanke på fremtiden enn før 
 2 Jeg forventer at ting ikke vil gå i orden for meg 
 3 Jeg føler at fremtiden min er håpløs og at alt bare blir verre 
 
3. 0 Jeg føler meg ikke mislykket 
 1 Jeg har mislyktes mer enn jeg burde 
 2 Når jeg ser tilbake ser jeg mange nederlag 
 3 Jeg føler meg som en fullstendig mislykket person 
 
4. 0 Jeg får like mye glede ut av ting jeg liker som før 
 1 Jeg får ikke like mye glede ut av ting jeg liker som før 
 2 Jeg får svært liten glede ut av de tingene som jeg pleide å like 
 3 Jeg får ingen glede ut av de tingene jeg pleide å like 
 
5. 0 Jeg føler ikke særlig mye skyld  
 1 Jeg føler skyld for mange ting jeg har gjort eller burde gjøre 
 2 Jeg føler skyld mesteparten av tiden 
 3 Jeg føler skyld hele tiden 
 
6. 0 Jeg føler ikke at jeg blir straffet 
 1 Jeg føler det som om jeg kan bli straffet 
 2 Jeg forventer å bli straffet 
 3 Jeg føler det som om jeg blir straffet 
 
7. 0 Mitt selvbilde er uforandret 
 1 Jeg har fått mindre selvtillit 
 2 Jeg er skuffet over meg selv 
 3 Jeg misliker meg selv 
 
8. 0 Jeg kritiserer eller bebreider ikke meg selv mer enn vanlig 
 1 Jeg kritiserer meg selv mer enn jeg pleide 
 2 Jeg kritiserer meg selv for alle mine feil 
 3 Jeg klandrer meg selv alt leit som skjer 
 
9. 0 Jeg har ingen tanker om å ta livet mitt 
 1 Jeg har tanker om å ta livet mitt, men kommer ikke til å gjøre det 
 2 Jeg ønsker å ta livet mitt 
 3 Jeg ville tatt livet mitt hvis jeg fikk mulighet til det 
 
10. 0 Jeg gråter ikke mer enn før 
 1 Jeg gråter mer enn før 
 2 Jeg gråter for hver minste ting 
 3 Jeg ønsker å gråte men klarer det ikke 
 
11. 0 Jeg er ikke mer urolig eller rastløs enn vanlig 
 1 Jeg føler meg mer rastløs eller urolig enn vanlig  
2 Jeg er så urolig og rastløs at det er vanskelig å være i ro 
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12. 0 Jeg har ikke mistet interessen for andre mennesker eller aktiviteter 
 1 Jeg er mindre interessert i andre mennesker eller ting enn tidligere 
 2 Jeg har mistet det meste av interesse for andre mennesker eller ting 
 3 Det er vanskelig å bli interessert i noe som helst 
 
13. 0 Jeg tar beslutninger like lett som før 
 1 Jeg synes det er vanskeligere å ta beslutninger 
 2 Jeg har mye større vanskeligheter med å ta beslutninger enn før 
 3 Jeg har vanskeligheter med å ta enhver beslutning 
 
14. 0 Jeg føler meg ikke verdiløs 
 1 Jeg opplever meg ikke like verdifull og nyttig som før 
 2 Jeg føler meg mer verdiløs enn andre mennesker 
 3 Jeg føler meg fullstendig verdiløs 
 
15. 0  Jeg har like mye energi som før 
 1 Jeg har mindre energi enn jeg pleide 
 2 Jeg har ikke nok energi til å gjøre særlig mye 
 3 Jeg har ikke nok energi til å gjøre noe som helst 
 
13. A Jeg har ikke merket noen endringer i søvnen min 
 B Jeg sover litt mer enn vanlig 
 C Jeg sover litt mindre enn vanlig 
 D Jeg sover mye mer enn vanlig 
 E Jeg sover mye mindre enn vanlig 
F Jeg sover mesteparten av døgnet 
G Jeg våkner 2 timer for tidlig og får ikke sove igjen 
 
17. 0 Jeg er ikke mer irritabel enn vanlig 
 1 Jeg er mer irritert enn vanlig 
 2 Jeg er mye mer irritabel enn vanlig 
 3 Jeg er irritabel hele tiden 
 
18. A Jeg har ikke merket noen endringer i min matlyst 
 B Min matlyst er litt mindre enn vanlig 
 C Min matlyst er litt større enn vanlig 
 D Min matlyst er mye mindre enn vanlig 
 E Min matlyst er mye større enn vanlig 
 F Jeg har ingen matlyst i det hele tatt 
 G Jeg føler trang til å spise hele tiden 
 
19. 0 Jeg kan konsentrere meg like bra som før 
 1 Jeg kan ikke konsentrere meg like godt som før 
 2 Jeg har vanskelig for å konsentrere meg 
 3 Jeg merker at jeg ikke kan konsentrere meg om noe som helst 
 
20. 0 Jeg er ikke mer trøtt eller utmattet enn tidligere 
 1 Jeg blir fortere trøtt eller utmattet enn jeg pleier 
 2 Jeg er for trøtt eller utmattet til å gjøre mange av de tingene jeg pleide å gjøre 
 3 Jeg er for trøtt eller utmattet til å gjøre mesteparten av de tingene jeg pleide å gjøre 
 
21. 0 Jeg har ikke merket noen endringer i min interesse for sex i det siste 
 1 Jeg er mindre interessert i sex i det siste 
 2 Jeg er mye mindre interessert i sex i det siste 
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